Delivery Order SPE2DB25D3012-SPE2DB25FWYRX
Award Date 7/17/25
Potential Completion Date 8/7/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,421.17, is for the delivery of 4566912303 INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 4, 2025. This award is associated with a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,895.72 firm fixed-price delivery order is for the supply of INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 31, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,075.39 firm fixed-price delivery order is for the supply of 4566187849 INLYTA 1 MG TABLET 180S, a prescription medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on October 23, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,895.72, is for the delivery of INLYTA 5 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of July 15, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant...
- This is a $23,847.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INLYTA 1 MG TABLET 180S, a pharmaceutical product, with a period of performance through June 10, 2025. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $11,895.72 and covers the delivery of Inlyta 5 mg tablets. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60 units of the medication INLYTA 5 MG TABLET, with a firm fixed price of $11,895.72 and a completion date of June 27, 2025. The contract is not set-aside and was awarded on June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,895.72, is for the delivery of Inlyta 5 mg tablets. It is a firm fixed-price contract with a performance period through May 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,685.92 Firm Fixed Price Delivery Order is for the supply of 4562901756 - INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,039.62 firm-fixed-price delivery order is for the supply of Inlyta 5 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYRXDelivery Order
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) valued at $11,895.72. The contract is for the delivery of INLYTA 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on August 7, 2025. The award was made on July 17, 2025, and is a firm fixed-price contract. This IDC, designated as SPE2DX, has a maximum potential value of $999,999,999.00 and runs through December 2026, providing comprehensive global pharmaceutical support to military healthcare programs. The contract is not a set-aside award.
Generated 10/16/25, 10:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 7/17/25 |